Author: "Streicher, Katie" / Publisher: american association for cancer research (aacr) - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Streicher, Katie"' showing total 40 results

Start Over Author "Streicher, Katie" Publisher american association for cancer research (aacr)

40 results on '"Streicher, Katie"'

1. Data from A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade

Author: Lazdun, Yelena, primary, Si, Han, primary, Creasy, Todd, primary, Ranade, Koustubh, primary, Higgs, Brandon W., primary, Streicher, Katie, primary, and Durham, Nicholas M., primary
Published: 2023
Full Text: View/download PDF

2. Supplementary Data, Supplementary Table 1, Supplementary Figures 1-9 from A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade

Author: Lazdun, Yelena, primary, Si, Han, primary, Creasy, Todd, primary, Ranade, Koustubh, primary, Higgs, Brandon W., primary, Streicher, Katie, primary, and Durham, Nicholas M., primary
Published: 2023
Full Text: View/download PDF

3. Supplementary Data, Supplementary Table 1, Supplementary Figures 1-9 from A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade

Author: Lazdun, Yelena, primary, Si, Han, primary, Creasy, Todd, primary, Ranade, Koustubh, primary, Higgs, Brandon W., primary, Streicher, Katie, primary, and Durham, Nicholas M., primary
Published: 2023
Full Text: View/download PDF

4. Data from A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade

Author: Lazdun, Yelena, primary, Si, Han, primary, Creasy, Todd, primary, Ranade, Koustubh, primary, Higgs, Brandon W., primary, Streicher, Katie, primary, and Durham, Nicholas M., primary
Published: 2023
Full Text: View/download PDF

5. Supplementary Figure S3 from Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Author: Higgs, Brandon W., primary, Morehouse, Christopher A., primary, Streicher, Katie, primary, Brohawn, Philip Z., primary, Pilataxi, Fernanda, primary, Gupta, Ashok, primary, and Ranade, Koustubh, primary
Published: 2023
Full Text: View/download PDF

6. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

7. Supplemental Material from Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Author: Higgs, Brandon W., primary, Morehouse, Christopher A., primary, Streicher, Katie, primary, Brohawn, Philip Z., primary, Pilataxi, Fernanda, primary, Gupta, Ashok, primary, and Ranade, Koustubh, primary
Published: 2023
Full Text: View/download PDF

8. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

9. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

10. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

11. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

12. Figure S3 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

13. Figure S5 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

14. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

15. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

16. Figure S1 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

17. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

18. Figure S1 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

19. Figure S4 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

20. Supplementary Figure S2 from Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Author: Higgs, Brandon W., primary, Morehouse, Christopher A., primary, Streicher, Katie, primary, Brohawn, Philip Z., primary, Pilataxi, Fernanda, primary, Gupta, Ashok, primary, and Ranade, Koustubh, primary
Published: 2023
Full Text: View/download PDF

21. Figure S2 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

22. Figure S2 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

23. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

24. Figure S4 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

25. Figure S3 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

26. Supplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., primary, Curti, Brendan, primary, Pedersen, Katrina S., primary, Bauer, Todd M., primary, Groenland, Stefanie L., primary, Carvajal, Richard D., primary, Chhaya, Vaishali, primary, Kirby, Gray, primary, McGlinchey, Kelly, primary, Hammond, Scott A., primary, Streicher, Katie, primary, Townsley, Danielle M., primary, Chae, Young Kwang, primary, Voortman, Jens, primary, Marabelle, Aurelien, primary, and Powderly, John, primary
Published: 2023
Full Text: View/download PDF

27. Figure S5 from Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., primary, Ferris, Robert L., primary, Powderly, John, primary, Rizvi, Naiyer A., primary, Keam, Bhumsuk, primary, Schneider, Reva, primary, Goel, Sanjay, primary, Ohr, James P., primary, Burton, Jennifer, primary, Zheng, Yanan, primary, Eck, Steven, primary, Gribbin, Matthew, primary, Streicher, Katie, primary, Townsley, Danielle M., primary, and Patel, Sandip Pravin, primary
Published: 2023
Full Text: View/download PDF

28. Abstract 5547: EGFR inhibition decreases immunosuppressive cytokines and reduces growth in STK11 mutant NSCLC

Author: Lazdun, Yelena, primary, Greenlees, Lydia, additional, Wu, Song, additional, Holoweckyj, Nicholas, additional, Pilataxi, Fernanda, additional, Hayes, Susana, additional, Higgs, Brandon, additional, and Streicher, Katie, additional
Published: 2022
Full Text: View/download PDF

29. Abstract 3197: Blockade of regulatory signaling pathways reduces immunosuppression in the PDAC tumor microenvironment

Author: Greenlees, Lydia, primary, Cheng, Li, additional, Omar, Bilal, additional, Lazdun, Yelena, additional, Wang, Jixin, additional, Pilataxi, Fernanda, additional, Kuziora, Michael, additional, Cooper, Zachary, additional, Vence, Luis, additional, and Streicher, Katie, additional
Published: 2022
Full Text: View/download PDF

30. Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors

Author: Goldman, Jonathan W., primary, Piha-Paul, Sarina A., additional, Curti, Brendan, additional, Pedersen, Katrina S., additional, Bauer, Todd M., additional, Groenland, Stefanie L., additional, Carvajal, Richard D., additional, Chhaya, Vaishali, additional, Kirby, Gray, additional, McGlinchey, Kelly, additional, Hammond, Scott A., additional, Streicher, Katie, additional, Townsley, Danielle M., additional, Chae, Young Kwang, additional, Voortman, Jens, additional, Marabelle, Aurelien, additional, and Powderly, John, additional
Published: 2022
Full Text: View/download PDF

31. A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade

Author: Lazdun, Yelena, primary, Si, Han, additional, Creasy, Todd, additional, Ranade, Koustubh, additional, Higgs, Brandon W., additional, Streicher, Katie, additional, and Durham, Nicholas M., additional
Published: 2021
Full Text: View/download PDF

32. Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Author: Glisson, Bonnie S., primary, Leidner, Rom S., additional, Ferris, Robert L., additional, Powderly, John, additional, Rizvi, Naiyer A., additional, Keam, Bhumsuk, additional, Schneider, Reva, additional, Goel, Sanjay, additional, Ohr, James P., additional, Burton, Jennifer, additional, Zheng, Yanan, additional, Eck, Steven, additional, Gribbin, Matthew, additional, Streicher, Katie, additional, Townsley, Danielle M., additional, and Patel, Sandip Pravin, additional
Published: 2020
Full Text: View/download PDF

33. Abstract 5718: miRNA-629: A circulating exosomal biomarker of NK cell function

Author: Lazdun, Yelena, primary, Greenlees, Lydia M., additional, Pilataxi, Fernanda, additional, Rayanki, Radhika, additional, and Streicher, Katie, additional
Published: 2020
Full Text: View/download PDF

34. Abstract 5544: Newcastle Disease Virus in human derived tumors: Understanding immune recruitment and activation via virally delivered IL-12

Author: Durham, Nicholas M., primary, McGlinchey, Kelly, additional, Burke, Shannon, additional, Creasy, Todd, additional, Rath, Nicola, additional, Monks, Noel, additional, Tammali, Ravinder, additional, Schifferli, Kevin, additional, Holoweckyj, Nick, additional, Hayes, Susie, additional, Jones, Emma, additional, Kelly, Elizabeth J., additional, Carroll, Danielle, additional, Harper, James, additional, and Streicher, Katie, additional
Published: 2020
Full Text: View/download PDF

35. Abstract 911: Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR mutant NSCLC

Author: Tu, Eric, primary, McGlinchey, Kelly, additional, Lazdun, Yelena, additional, Kurasawa, James, additional, Wilson, Susan, additional, Wetzel, Leslie, additional, Coffman, Karen, additional, Cooper, Zachary, additional, and Streicher, Katie, additional
Published: 2020
Full Text: View/download PDF

36. Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Author: Higgs, Brandon W., primary, Morehouse, Christopher A., additional, Streicher, Katie, additional, Brohawn, Philip Z., additional, Pilataxi, Fernanda, additional, Gupta, Ashok, additional, and Ranade, Koustubh, additional
Published: 2018
Full Text: View/download PDF

37. Abstract 5268: Differential expression of insulin receptor isoforms in human lung cancer.

Author: Huang, Jiaqi, primary, Streicher, Katie, additional, Morehouse, Chris, additional, Lehmann, Kim, additional, Brohawn, Philip, additional, Zhu, Wei, additional, Czapiga, Meggan, additional, LaVallee, Theresa, additional, Mitz, Karen, additional, Richman, Laura, additional, Jallal, Bahija, additional, and Yao, Yihong, additional
Published: 2013
Full Text: View/download PDF

38. Abstract 327: Altered expression of insulin receptor isoforms in breast cancer

Author: Jiaqi, Huang, primary, Morehouse, Chris, additional, Streicher, Katie, additional, Higgs, Brandon W., additional, Gao, Jin, additional, Baffa, Raffaele, additional, Meggan, Czapiga, additional, Boutrin, Anmarie, additional, Brohawn, Philip, additional, Zhu, Wei, additional, LaVallee, Theresa, additional, Chang, Yong, additional, Richman, Laura, additional, Jallal, Bahija, additional, and Yao, Yihong, additional
Published: 2011
Full Text: View/download PDF

39. Activation of a Nuclear Factor κB/Interleukin-1 Positive Feedback Loop by Amphiregulin in Human Breast Cancer Cells

Author: Streicher, Katie L., primary, Willmarth, Nicole E., additional, Garcia, Jose, additional, Boerner, Julie L., additional, Dewey, T. Gregory, additional, and Ethier, Stephen P., additional
Published: 2007
Full Text: View/download PDF

40. Multiple Interacting Oncogenes on the 8p11-p12 Amplicon in Human Breast Cancer

Author: Yang, Zeng Quan, primary, Streicher, Katie L., additional, Ray, Michael E., additional, Abrams, Judith, additional, and Ethier, Stephen P., additional
Published: 2006
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Publication Year Range

Journal

Database

40 results on '"Streicher, Katie"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources